SI1493441T1 - Terapevtsko sredstvo za motnjo prilagoditve Ĺľelodca na zauĹľito prehrano - Google Patents

Terapevtsko sredstvo za motnjo prilagoditve Ĺľelodca na zauĹľito prehrano

Info

Publication number
SI1493441T1
SI1493441T1 SI200332073T SI200332073T SI1493441T1 SI 1493441 T1 SI1493441 T1 SI 1493441T1 SI 200332073 T SI200332073 T SI 200332073T SI 200332073 T SI200332073 T SI 200332073T SI 1493441 T1 SI1493441 T1 SI 1493441T1
Authority
SI
Slovenia
Prior art keywords
group
therapeutic agent
competence
stomach
disorder
Prior art date
Application number
SI200332073T
Other languages
English (en)
Inventor
Yugo Matsunaga
Shigeru Ueki
Raita Higashino
Masanao Kawachi
Hiroki Kato
Shiro Kobayashi
Original Assignee
Zeria Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28786350&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1493441(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zeria Pharm Co Ltd filed Critical Zeria Pharm Co Ltd
Publication of SI1493441T1 publication Critical patent/SI1493441T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI200332073T 2002-04-08 2003-04-08 Terapevtsko sredstvo za motnjo prilagoditve Ĺľelodca na zauĹľito prehrano SI1493441T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002104894 2002-04-08
EP03745958A EP1493441B1 (en) 2002-04-08 2003-04-08 Therapeutic agent for food competence disorder in stomach
PCT/JP2003/004445 WO2003084537A1 (fr) 2002-04-08 2003-04-08 Agent therapeutique traitant les troubles stomacaux de competence alimentaire

Publications (1)

Publication Number Publication Date
SI1493441T1 true SI1493441T1 (sl) 2011-12-30

Family

ID=28786350

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200332073T SI1493441T1 (sl) 2002-04-08 2003-04-08 Terapevtsko sredstvo za motnjo prilagoditve Ĺľelodca na zauĹľito prehrano

Country Status (14)

Country Link
US (4) US20050176788A1 (sl)
EP (2) EP1493441B1 (sl)
JP (2) JP5281226B2 (sl)
KR (4) KR20050002925A (sl)
CN (2) CN102125551B (sl)
AT (1) ATE522214T1 (sl)
AU (1) AU2003236326B2 (sl)
CA (1) CA2481916C (sl)
CY (1) CY1112057T1 (sl)
DK (1) DK1493441T3 (sl)
ES (1) ES2368732T3 (sl)
PT (1) PT1493441E (sl)
SI (1) SI1493441T1 (sl)
WO (1) WO2003084537A1 (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104447612A (zh) * 2013-09-16 2015-03-25 天津市汉康医药生物技术有限公司 阿考替胺水合物晶型及其制备方法和用途
CN103980226A (zh) * 2014-05-10 2014-08-13 杭州新博思生物医药有限公司 盐酸阿考替胺水合物晶型及其制备方法
CN105315225A (zh) * 2014-07-07 2016-02-10 中美华世通生物医药科技（武汉）有限公司 阿考替胺的酸加成盐及其制备方法
CN104045606B (zh) * 2014-07-11 2015-09-30 杭州新博思生物医药有限公司 一锅法制备阿考替胺盐酸盐的方法
CN109988121B (zh) * 2019-04-28 2023-01-03 梯尔希（南京）药物研发有限公司 一种阿考替胺衍生物的制备方法
AR126442A1 (es) 2021-07-14 2023-10-11 Blueprint Medicines Corp Inhibidores de map4k1

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1063442C (zh) 1995-05-18 2001-03-21 泽里新药工业株式会社 氨基噻唑衍生物、含有它们的药物组合物及其用途
JPH10212271A (ja) * 1997-01-31 1998-08-11 Zeria Pharmaceut Co Ltd Ｎ−置換ベンゾイルアミン誘導体、それを含有する医薬及び該化合物の製造中間体
US6197970B1 (en) * 1997-06-24 2001-03-06 Zeria Pharmaceutical Co., Ltd. Process for producing 2-hydroxybenzamide derivatives
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
KR20010080025A (ko) * 1998-11-23 2001-08-22 디르크 반테 소화불량 치료용 의약의 제조를 위한 프루칼로프라이드의용도
JP2003501427A (ja) * 1999-06-02 2003-01-14 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ アミノアルキル置換（ベンゾジオキサン、ベンゾフランもしくはベンゾピラン）誘導体
DE60025261T2 (de) * 1999-11-23 2006-08-24 Janssen Pharmaceutica N.V. Verwendung von 5ht3 antagonisten zur fundusentspannung
GB0002336D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
DK1315488T3 (da) * 2000-09-08 2007-02-12 Zeria Pharm Co Ltd Farmaceutiske sammensætninger indeholdende aminothiazolderivater til behandling af motoriske funktionsforstyrrelser af tyktarm
US6986882B2 (en) * 2002-01-17 2006-01-17 Astrazeneca Ab Therapy for functional dyspepsia

Also Published As

Publication number Publication date
AU2003236326B2 (en) 2008-02-28
KR20120037035A (ko) 2012-04-18
JP5281226B2 (ja) 2013-09-04
US20090156652A1 (en) 2009-06-18
CY1112057T1 (el) 2015-11-04
JP2011068692A (ja) 2011-04-07
CN102125551A (zh) 2011-07-20
US20150141475A1 (en) 2015-05-21
KR20130101162A (ko) 2013-09-12
EP2301540A1 (en) 2011-03-30
US20200375954A1 (en) 2020-12-03
ATE522214T1 (de) 2011-09-15
EP1493441A1 (en) 2005-01-05
CA2481916A1 (en) 2003-10-16
KR101423284B1 (ko) 2014-07-24
EP1493441A4 (en) 2007-10-17
JP5360075B2 (ja) 2013-12-04
JPWO2003084537A1 (ja) 2005-08-11
US20050176788A1 (en) 2005-08-11
ES2368732T3 (es) 2011-11-21
AU2003236326A1 (en) 2003-10-20
WO2003084537A1 (fr) 2003-10-16
CA2481916C (en) 2013-02-26
EP1493441B1 (en) 2011-08-31
PT1493441E (pt) 2011-09-28
DK1493441T3 (da) 2011-10-17
CN1646123A (zh) 2005-07-27
KR20050002925A (ko) 2005-01-10
CN102125551B (zh) 2015-07-22
KR20110010837A (ko) 2011-02-07

Similar Documents

Publication Publication Date Title
EP1775289A4 (en) NEW IMIDAZOLIDINE DERIVATIVES
IL148384A0 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
MY136581A (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
EP1679309A4 (en) ANTISTRESS MEDICAMENT AND ITS MEDICAL USE
AU2006325931A8 (en) Amine compound and use thereof for medical purposes
EP1092435A4 (en) ANTIDIABETIC DRUGS
EP1634874A4 (en) imidazolidine
SI1970372T1 (sl) Soli 9-oksoakridin-10-ocetne kisline z 1-alkilamino-1-deoksi-polioli
EP1493441A4 (en) THERAPEUTIC AGENT TREATING STOMACH DISORDERS OF FOOD COMPETENCE
HK1129071A1 (en) Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
HK1077070A1 (en) Oligosaccharide derivative
MY122570A (en) Benzamide derivatives and drugs containing the same
HK1130496A1 (en) 3'-ethynylcytidine derivative 3'-
EP1734046A4 (en) radiosensitizing
TW200505892A (en) Substituted 3-(benzoylureido)thiophene derivatives, processes for preparing them and their use
EP1500656A4 (en) BIGUANIDE DERIVATIVE AND DIABETES TREATMENT AGENT CONTAINING
NO993911D0 (no) Remedier/Forebygningsmidler for åndedrettssykdommer
PL1924255T3 (pl) Zastosowanie N-(dibenz(b,f)oksepin-10-ylometylo)-N-metylo-N-prop-2-ynyloaminy (OMIGAPIL)
MXPA06000651A (es) Uso de derivados de indazol para el tratamiento de dolor neuropatico.
MX2008002753A (es) Derivados de piridazinona utilizados para el tratamiento de dolor.